NCT04460638View on ClinicalTrials.gov

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling

CompletedOBSERVATIONAL
Enrollment

779

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
SARS-CoV 2
Interventions
BIOLOGICAL

Saliva collection

Saliva samples are regularly collected over a period of up to 30 consecutive days.

OTHER

Clinical assessment

The participant's clinical data will be collected regularly over a period of up to 30 consecutive days.

Trial Locations (1)

13013

Hôpital d'Instruction des Armées Laveran, Marseille

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER

NCT04460638 - SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling | Biotech Hunter | Biotech Hunter